PCMA Articles
New Episode Of “The Pharmacy Benefit” Podcast Discusses Why We Need Competition To Drive Down Prescription Drug Costs
Alex Brill and Angela Banks Dive into the Critical Need for Competition, Big Drug Companies’ Abuse of the Patent System,
Small And Mid-Sized Employers Rely On Spread Pricing For Predictable, Fixed Pricing
Pharmacy Benefit Companies Provide Employers with Coverage Choices and Flexibilities t hat Work for their Unique Needs Pharmacy benefit companies
Rebates Secured by Pharmacy Benefit Companies Result in Savings for Patients and Employers — and Have No Correlation to High Drug Prices
Pharmacy benefit companies push big drug companies for price concessions through rebates. 99.6 percent of rebates get passed directly to
Expert Witness and Lawmakers Highlight Root Cause of High Rx Prices: Big Pharma’s Anti-Competitive Tactics
Hearing Confirms Big Drug Companies Would Benefit from Misguided Proposals Targeting Pharmacy Benefits This week, the U.S. House Committee on
Pharmacy Benefit Companies Lower Rx Costs and Provide Critical Flexibility for Employers and Labor Unions
The evidence is clear: pharmacy benefit companies lower prescription drug costs for employers, labor union plans, taxpayers, and patients. While
Expert Witness and Lawmakers Highlight Root Cause of High Rx Costs – Big Drug Companies’ Anti-Competitive Tactics
Last week, the U.S. House Ways and Means Committee Health Subcommittee held a hearing on “Why Health Care is Unaffordable:
Pharmacy Benefit Companies Highlight Critical Role of Making Insulin Affordable and Accessible for All Americans at Senate Hearing
Pharmacy Benefit Companies Negotiate with Big Drug Companies to Lower Prescription Drug Costs for Patients and Families Last week, the
Market Forces Working to Lower Insulin Costs
Encouraging Signs that the Insulin Affordability Battle is Improving This week, as congressional hearings focus on access to affordable insulins,
Sorry, no posts matched your criteria.
